A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine.
暂无分享,去创建一个
C. Porter | W. Charman | C J Porter | W N Charman | A. Humberstone | A J Humberstone | Christopher J.H. Porter | Andrew J. Humberstone
[1] A. Breckenridge,et al. Pharmacokinetics of halofantrine in man: effects of food and dose size. , 1989, British journal of clinical pharmacology.
[2] M A Mintun,et al. Dissolution kinetics of carboxylic acids I: effect of pH under unbuffered conditions. , 1981, Journal of pharmaceutical sciences.
[3] H. Webster,et al. Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria , 1993, The Lancet.
[4] H. Webster,et al. Malaria: treatment efficacy of halofantrine (WR 171,669) in initial field trials in Thailand. , 1988, Bulletin of the World Health Organization.
[5] S. Ward,et al. Pharmacokinetics of halofantrine in Thai patients with acute uncomplicated falciparum malaria. , 1991, British journal of clinical pharmacology.
[6] M. Mintun,et al. Dissolution kinetics of phenylbutazone. , 1981, Journal of pharmaceutical sciences.
[7] G. Shanks,et al. Efficacy and tolerance of extended-dose halofantrine for drug-resistant falciparum malaria in Thailand. , 1994, The American journal of tropical medicine and hygiene.
[8] D. Kyle,et al. Pharmacokinetics, efficacy and toxicity of parenteral halofantrine in uncomplicated malaria. , 1993, British journal of clinical pharmacology.
[9] H. Pohle,et al. The efficacy of halofantrine in the treatment of acute malaria in nonimmune travelers. , 1992, The American journal of tropical medicine and hygiene.
[10] D. Crommelin,et al. Dissolution rate of griseofulvin in bile salt solutions. , 1991, Journal of pharmaceutical sciences.
[11] P. Stilbs. Fourier transform NMR pulsed-gradient spin—echo (FT-PGSE) self-diffusion measurements of solubilization equilibria in SDS solutions , 1982 .
[12] D. Crommelin,et al. Dissolution kinetics of griseofulvin in mixed micellar solutions. , 1994, Journal of pharmaceutical sciences.
[13] C. Porter,et al. A simplified liquid chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditions. , 1995, Journal of pharmaceutical and biomedical analysis.
[14] C. Porter,et al. Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion. , 1996, Journal of pharmaceutical sciences.
[15] T. Kararli. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals , 1995, Biopharmaceutics & drug disposition.
[16] S. Looareesuwan,et al. Clinical trials with halofantrine in acute uncomplicated falciparum malaria in Thailand. , 1993, The Southeast Asian journal of tropical medicine and public health.
[17] A. J. Repta,et al. Solubilization and stabilization of an investigational antineoplastic drug (NSC no. 278214) in an intravenous formulation using an emulsion vehicle , 1983 .
[18] J. Meyer,et al. The antimalarial drug halofantrine is bound mainly to low and high density lipoproteins in human serum. , 1995, British journal of clinical pharmacology.
[19] D. Kariuki,et al. EFFICACY OF MULTIPLE-DOSE HALOFANTRINE IN TREATMENT OF CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN CHILDREN IN KENYA , 1988, The Lancet.